• Press Release

Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery

  • New York, NY
  • (July 29, 2021)

J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021. With more than 600 members worldwide, the organization’s mission is to promote the highest quality, comprehensive, minimally-invasive care for patients with stroke, brain aneurysms, and other diseases of the head, neck and spine.

Dr. Mocco is an internationally recognized cerebrovascular and endovascular neurosurgeon, with clinical interests in stroke, brain aneurysms, subarachnoid hemorrhage, arteriovenous malformations, cavernous malformations, and carotid artery stenosis. His research interests focus on translational efforts to treat ischemic and hemorrhagic stroke. He has published more than 525 peer-reviewed publications, edited three textbooks on neurosurgical techniques, and runs numerous national and international clinical trials to improve the treatment of patients with cerebrovascular disease.

“An internationally acclaimed neurosurgeon known for tirelessly advancing science to attain the highest quality of care for patients with cerebrovascular diseases, Dr. Mocco strives to globally transform the field of endovascular neurosurgery through his innovative ideas, novel administrative strategies, groundbreaking research, and inspiring leadership. A mentor and educator for neurosurgery residents and fellows, Dr. Mocco is dedicated to expanding the boundaries of conventional practice to help improve the lives of patients around the world,” said Joshua B. Bederson, MD, Chair of Neurosurgery at Mount Sinai Health System. “We are delighted that the Society of NeuroInterventional Surgery has chosen him as president-elect. This role will further enable Dr. Mocco to share his visionary leadership with people around the world who study and treat these conditions.”

Dr. Mocco received his medical degree from Columbia University College of Physicians and Surgeons. He earned a Master of Science degree in Biostatistics from the Mailman School of Public Health at Columbia University, did his residency in neurological surgery at the Neurological Institute of New York, and completed a fellowship in endovascular neurosurgery from the University at Buffalo. Prior to joining the Icahn School of Medicine at Mount Sinai in 2014, Dr. Mocco held clinical and academic positions at the University of Buffalo, the University of Florida, and Vanderbilt University Medical Center.  

Dr. Mocco has been a principal investigator of more than two dozen research trials and is the recipient of numerous honors and awards in his field. He is the first person to serve as President-elect of the Society for NeuroInterventional Surgery and as Chair of the Cerebrovascular Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons. 

Dr. Mocco will assume the presidency in July 2022.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.